The Response to Intralesional IL-2 and/or BCG Treatment for Cutaneous Metastatic Melanoma

NCT03928275 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Withdrawn prematurely.

Conditions

Cutaneous Metastatic Melanoma

Interventions

BIOLOGICAL: Interleukin-2
BIOLOGICAL: Combination therapy Interleukin-2 and Bacillus Calmette Guerin

Sponsor

Carman Giacomantonio

Collaborators

[object Object]